In 2007, the National Comprehensive Cancer Network guidelines for prostate cancer detection suggested that men with a PSA velocity higher than 0.35 ng/mL/y should consider biopsy, even if their PSA concentration is low (18). This evidence concerns the gene KLK3 and prostate carcinoma.